Mice Lacking p27Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors

Cell

Volumn 85, Issue 5, 1996, Pages 707-720

  Nakayama, Keiko ^a,b   Ishida, Noriko ^a   Shirane, Michiko ^a   Inomata, Akira ^a   Inoue, Tomoaki ^a   Shishido, Nobuyuki ^a   Horii, Ikuo ^a   Loh, Dennis Y ^a,b   Nakayama, Kei Ichi ^a,b  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

RAPAMYCIN;

ANIMAL CELL; ARTICLE; BODY SIZE; CELL CYCLE; CELL PROLIFERATION; CONTACT INHIBITION; FEMALE STERILITY; GENE MUTATION; GENE TARGETING; HYPERPLASIA; HYPOPHYSIS TUMOR; MOUSE; NONHUMAN; OVARY FOLLICLE; PRIORITY JOURNAL; RETINA MALFORMATION; STEM CELL;

ANIMALS; BASE SEQUENCE; BODY CONSTITUTION; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; GENE TARGETING; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HYPERPLASIA; INFERTILITY, FEMALE; MALE; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; PHENOTYPE; PITUITARY NEOPLASMS; POLYENES; RETINAL DYSPLASIA; SIROLIMUS; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 0030010591     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81237-4     Document Type: Article

References (65)

1. Ahuja, S.S., Paliogianni, F., Yamada, H., Balow, J.E., and Boumpas, D.T. (1993). Effect of transforming growth factor-β on early and late activation events in human T cells. J. Immunol. 150, 3109-3118.
2. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T., and Hannon, G.J. (1995). Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-557.
3. Kip1, to regions involved in human cancer. Cancer Res. 55, 1199-1205.
4. ink4. Mol. Cell. Biol. 15, 2682-2688.
5. Chan, L.C., Kwong, Y.L., Liu, H.W., Lee, C.P., Lie, K.W., and Chan, A.Y. (1992). Deletion 12p in de novo acute myeloid leukemia: an association with early progenitor cell. Cancer Genet. Cytogenet. 62, 47-49.
6. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. Decker, H.J., Li, F.P., Bixenman, H.A., and Sandberg, A.A. (1990). Chromosome 3 and 12p rearranged in a well-differentiated peritoneal mesothelioma. Cancer Genet. Cytogenet. 46, 135-137.
8. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
9. Egerton, M., Scollay, R., and Shortman, K. (1990). Kinetics of mature T-cell development in the thymus. Proc. Natl. Acad. Sci. USA 87, 2579-2582.
10. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
11. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9, 2364-2372.
12. Fehling, H.J., Krotkova, A., Saint-Ruf, C., and von Boehmer, H. (1995). Crucial role of the pre-T-cell receptor α gene in development of αβ but not γδ T cells. Nature 375, 795-798.
13. Firpo, E.J., Koff, A., Solomon, M.J., and Roberts, J.M. (1994). Inactivation of a cdk2 inhibitor during interleukin-2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14, 4889-4901.
14. Gillett, C., Ranti, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. (1994). Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54, 1812-1817.
15. Gu, Y., Turck, C.W., and Morgan, D.O. (1993). Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710.
16. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952.
17. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D., and Lassar, A.B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1021.
18. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 377, 257-261.
19. Harper, J.M., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
20. Hirai, H., Roussel, M.F., Kato, J.-Y, Ashmun, R.A., and Sherr, C.J. (1995). Novel Ink4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681.
21. Hunter, T., and Pines, J. (1994). Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
22. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A.T., Ally, D.S., Sheahan, M.D., Clark, W.H., Jr., Tucker, M.A., and Dracopoli, N.C. (1994). Germlinep 16 mutations in familial melanoma. Nature Genet. 8, 15-21.
23. Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A., and Weinberg, R.A. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
24. WAF1/CIP1 expression in the absence of p53. Oncogene 9, 3397-3406.
25. Kawamata, N., Morosetti, R., Miller, C.W., Park, D., Spirin, K.S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson J., Wilczynski, S., Lee, Y.Y., Bartram, C.R., and Koeffler, H.P. (1995). Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res. 55, 2266-2269.
26. Kehrl, J.H., Wakefield, L.M., Roberts, A.B., Jakowlew, S.B., Sporn, M.B., and Fauci, A.S. (1986). Production of transforming growth factor β by human lymphocytes and its potential role in the regulation of the T cell growth. J. Exp. Med. 163, 1037-1050.
27. Lammie, G.A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G. (1991). D11S128, a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6, 439-444.
28. Lee, E.Y.-H.P., Chang, C.-Y., Hu, N., Wang, Y.-C.J., Lai, C.-C., Herrup, K., Lee, W.-H., and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
29. Lee, K.P., Gibson, J.R., and Sherman, H. (1979). Retinipathic effects of 2-aminoxy propionic acid derivatives in the rat. Toxicol. Appl. Pharmacol. 57, 219-232.
30. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649.
31. Li, I., and Turner, J.E. (1988). Inherited retinal degeneration in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp. Eye Res. 47, 911-917.
32. Mansour, S., Thomas, K.R., and Capecchi, M.R. (1988). Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352.
33. CIP1 Cdk-inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662.
34. Mombaerts, P., Clarke, A.R., Rudnicki, M.A., Iacomini, J., Itohara, S., Lafaille, J.J., Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M.L., and Tonegawa, S. (1992). Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360, 225-231.
35. Mori, T., Miura, K., Aoki, T., Nishimura, T., Mori, S., and Nakamura, Y. (1994). Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54, 3396-3397.
36. Kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86, 1924-1930.
37. Motokura, T., Bloom, T., Kim, H.G., Juppner, H., Ruderman, J.V., Kronenberg, H.M., and Arnold, A. (1991). A novel cyclin encoded by a bcl-linked candidate oncogene. Nature 350, 512-515.
38. Nakayama, K.-i., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M.C., Fields, L.E., Lucas, P.J., Stewart, V., Alt, F.W., and Loh, D.Y. (1993). Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261, 1584-1588.
39. Nakayama, K.-i., Nakayama, K., Negishi, I., Kuida, K., Louie, M.C., Kanagawa, O., Nakauchi, H., and Loh, D.Y. (1994). Requirement for CDS β chain in positive selection of CD8-lineage T cells. Science 263, 1131-1133.
40. Noda, A., Ning, Y., Venable, S.F., Pereila-Smith, O.M., and Smith, J.R. (1994). Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98.
41. Noguchi, E., Sekiguchi, T., Yamashita, K., and Nishimoto, T. (1993). Molecular cloning and identification of two types of hamster cyclin-dependent kinases: cdk2 and cdk2L. Biochem. Biophys. Res. Commun. 197, 1524-1529.
42. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
43. Olsson, J.E., Gordon, J.W., Pawlyk, B.S., Roof, D., Hayes, A., Molday, R.S., Mukai, S., Cowley, G.S., Berson, E.L., and Dryja, T.P. (1992). Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 9, 815-830.
44. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P.R., Draetta, G.F., and Rolfe, M. (1995). Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
45. Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027.
46. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res. 55, 1206-1210.
47. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
48. KIP1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
49. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res. 55, 1211-1214.
50. Reynisdóttir, I., Polyak, K., Iavarone, A., and Massagué, J. (1995). Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831-1845.
51. Robertson, E.J. (1987). Embryo-derived stem cell lines. In Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, E.J. Robertson, ed. (Oxford: IRL Press), pp. 71-112.
52. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
53. Sherr, C.J. (1994). G1 phase progression: cycling on cue. Cell 79, 551-555.
54. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
55. Shinohara, M., El-Deiry, W.S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D.L., Vogelstein, B., and Koeffler, H.P. (1994). Absence of WAF1 mutations in a variety of human malignancies. Blood 84, 3781-3784.
56. Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N., and Doetschman, T. (1992). Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
57. Sicinski, P., Donaher, J.L., Parker, S.B., Li, T., Fazeli, A., Gardner, H., Haslam, S.Z., Bronson, R.T., Elledge, S.J., and Weinberg, R.A. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621-630.
58. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A., and El-Houseini, M.E. (1994). Induction of p21(WAF1/CIP1) during differentiation. Oncogene 9, 3389-3396.
59. Swyryd, E.A., Seaver, S., and Stark, G.R. (1974). N-(phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture. J. Biol. Chem. 249, 6945-6950.
60. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
61. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
62. Wahl, S.M., McCartney-Francis, N., and Mergenhagen, S.E. (1989). Inflammatory and immunomodulatory roles of TGF-β. Immunol. Today 10, 258-261.
63. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
64. Williams, B.O., Schmitt, E.M., Remington, L., Bronson, R.T., Albert, D.M., Weinberg, R.A., and Jacks, T. (1994). Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251-4259.
65. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.